Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1999
12/28/1999US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer
12/28/1999US6008219 Bicyclic amine derivatives and their use as anti-psychotic agents
12/28/1999US6008215 Benzonaphthyridines as bronchial therapeutics
12/28/1999US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/28/1999US6008196 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
12/28/1999US6008190 Cobalt Schiff base compounds
12/28/1999US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases
12/28/1999US6008039 Polynucleotide encoding a novel purinergic P2U receptor
12/28/1999US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999US6007841 Effective narcotic agonist-antagonist analgesic potentiated by concurrently administered nontoxic n-methyl-d-aspartate receptor antagonist
12/28/1999US6007834 Nasal melatonin composition
12/28/1999US6007824 Orally administering synergistic mixture of l-arginine, ginseng and zizyphi fructus to stimulate release of nitrogen monoxide and cause smooth muscle relaxation in human body
12/28/1999US6007821 Immunosuppression; organ transplants, insulin dependent diabetes
12/28/1999US6007803 Administering to mammal a cationic polymer to inhibit pathogenic toxins
12/28/1999US6007792 Chelate compounds labeled with technetium-99m, rhenium-186, or rhenium-188; tumor imaging
12/28/1999CA2155169C Process and compositions for activating the differentiation of preadipocyte cells and related therapeutic treatments
12/28/1999CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method
12/23/1999WO1999066075A2 Diagnostic method based on quantification of extramitochondrial dna
12/23/1999WO1999066065A2 Proteasomal activity
12/23/1999WO1999066060A1 Human mp52 gene promoter and method for exploring useful substance by using the same
12/23/1999WO1999066054A2 Erythropoietin analog-human serum albumin fusion protein
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066041A1 94 human secreted proteins
12/23/1999WO1999065947A2 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999WO1999065942A1 Cyclic somatostatin analogs
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999WO1999065936A2 Composition for the treatement of immune deficiencies and methods for its preparation and use
12/23/1999WO1999065934A1 Antithrombotic compounds
12/23/1999WO1999065933A1 Novel cyclosporins
12/23/1999WO1999065922A2 Prenyl transferase inhibitors
12/23/1999WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999WO1999065912A1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity
12/23/1999WO1999065910A1 Fused azepinone cyclin dependent kinase inhibitors
12/23/1999WO1999065907A1 Triazolo-pyrimidines as ligands for gaba receptors
12/23/1999WO1999065906A1 Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity
12/23/1999WO1999065904A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999WO1999065903A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999WO1999065887A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
12/23/1999WO1999065884A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065877A1 Therapeutic biaryl derivatives
12/23/1999WO1999065874A1 Benzanilide derivatives and medicinal compositions
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065571A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999WO1999065518A2 Lt and ct in parenteral immunization methods against helicobacter infection
12/23/1999WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors
12/23/1999WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999WO1999065509A1 Regulation of tyrosine hydroxylase
12/23/1999WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs
12/23/1999WO1999065500A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
12/23/1999WO1999065493A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/23/1999WO1999065492A1 Inhibition of serotonin reuptake
12/23/1999WO1999065491A1 Method of treatment
12/23/1999WO1999065490A2 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
12/23/1999WO1999065489A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065488A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999WO1999065487A1 Inhibitors of serotonin reuptake
12/23/1999WO1999065486A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999WO1999065481A1 Liposomal formulations of busulphan
12/23/1999WO1999065476A2 COMPOSITIONS FOR INCREASING ENERGY $i(IN VIVO)
12/23/1999WO1999065462A2 Use of aminosterol derivatives as chloride ionphores
12/23/1999WO1999065451A2 Caspases and apoptosis
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065310A1 Il-8 receptor antagonists
12/23/1999WO1999065309A1 Methods for increasing levels of acetylcholine
12/23/1999WO1999065307A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/23/1999WO1999065306A1 Methods for reducing levels of homocysteine and c-reactive protein
12/23/1999WO1999052516A3 Acylpeptide protease inhibitors to enhance cognitive function
12/23/1999WO1999049881A3 Application of hsp70 proteins
12/23/1999WO1999042578A3 Modulation of cell proliferation, methods and reagents
12/23/1999WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/23/1999WO1996002535A8 Process for synthesis of substituted sulphoxides
12/23/1999DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999DE19827732A1 Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
12/23/1999DE19827640A1 New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
12/23/1999DE19827523A1 New unsaturated 14,15-cyclopropano-androstanes useful in fertility control and for treating e.g. hypogonadism, endometriosis or mammary carcinoma
12/23/1999DE19827522A1 New derivatives of 19-norandrostane useful in fertility control or treatment of e.g. endometriosis, mammary carcinoma or hypogonadism
12/23/1999DE19827387A1 Use of ligands of the high affinity binding site of diisopropyl-fluorophosphate in treatment of central nervous system disorders
12/23/1999DE19826843A1 Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Imidazotriazolopyrimidine new, processes for their preparation and their use as medicaments
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999CA2337603A1 Prenyl transferase inhibitors
12/23/1999CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999CA2335487A1 Lt and ct in parenteral immunization methods against helicobacter infection
12/23/1999CA2335336A1 Inhibition of serotonin reuptake
12/23/1999CA2335322A1 Inhibitors of serotonin reuptake
12/23/1999CA2335306A1 Caspases and apoptosis
12/23/1999CA2335295A1 Methods for increasing levels of acetylcholine
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335292A1 Il-8 receptor antagonists
12/23/1999CA2335236A1 Method of treatment
12/23/1999CA2335184A1 Cyclic somatostatin analogs
12/23/1999CA2335134A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
12/23/1999CA2335112A1 Therapeutic combinations for musculoskeletal frailty
12/23/1999CA2335038A1 Combination of radiotherapy and anti-angiogenic factors
12/23/1999CA2334900A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
12/23/1999CA2334836A1 Triazolo-pyridine derivatives as ligands for gaba receptors
12/23/1999CA2334817A1 Triazolo-pyrimidines as ligands for gaba receptors
12/23/1999CA2334805A1 Use of aminosterol derivatives as chloride ionphores
1 ... 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 ... 1564